Sarepta Therapeutics, Inc. SRPT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $330.96M+217% | -$282.85M-57.2% | -$179.95M— | —— | -$447.51M-381% | ||
| $10.59M+102% | $5.25M-71.5% | $18.45M+70.2% | $10.84M+8.6% | $9.98M-4.6% | ||
| $29.4M-2.1% | $30.02M+101% | $14.93M-59.7% | $37.03M-10.6% | $41.43M-16.6% | ||
| -$202.68M— | —— | -$14.59M— | —— | -$583.44M— | ||
| $2.08M-42.0% | $3.59M-84.3% | $22.93M-27.9% | $31.8M-27.2% | $43.65M+14.6% | ||
| -$134.39M-240% | $96.21M— | —— | —— | -$291.18M-138% | ||
| $250M— | —— | —— | —— | $0— | ||
| $250M+613% | $35.09M— | —— | —— | $0— | ||
| $241K+101% | -$39.21M+66.7% | -$117.79M-395% | -$23.82M-291% | $12.47M-74.5% | ||
| -$336.83M— | —— | —— | —— | -$862.14M-195% | ||
| -$204.76M— | —— | -$37.52M— | —— | -$627.09M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sarepta Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Sarepta Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.